Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

725

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

JSKN003

JSKN003 should be administered intravenously on the first day of each 3-week cycle.

Trial Locations (34)

Unknown

Beijing Cancer Hospital, Beijing

Beijing Friendship Hospital, Beijing

Beijing Luhe Hospital, Beijing

Hunan Cancer Hospital, Changsha

Fujian Cancer Hospital, Fuzhou

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

Sun Yat-sen University Cancer Prevention Center, Guangzhou

Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Affiliated Cancer Hospital of Harbin Medical University, Ha’erbin

Anhui Provincal Hospital, Hefei

Shandong Cancer Hospital, Jinan

Linyi City Cancer Hospital, Linyi

Linyi City People's Hospital, Linyi

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

The Second Affiliated Hospital of Nanchang University, Nanchang

Gulou Hospital Affiliated to Nanjing University School of Medicine, Nanjing

Jiangsu Cancer Hospital, Nanjing

Jiangsu Provincial People's Hospital, Nanjing

The First Affiliated Hospital of Nanjing Medical University/Jiangsu Provincial People's Hospital, Nanjing

Affiliated Cancer Hospital of Guangxi Medical University, Nanning

Nantong Cancer Hospital, Nantong

Affiliated Hospital of Qingdao University, Qingdao

Affiliated Cancer Hospital of Fudan University, Shanghai

Changhai Hospital, Shanghai

Fudan University Shanghai Cancer Center, Shanghai

Shanghai East Hospital, Shanghai

The Second Affiliated Hospital of Soochow University, Suzhou

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

Xuzhou Central Hospital, Xuzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

INDUSTRY